46 Diseases of the Peripheral Nerves Flashcards
The most frequent electrodiagnostic findings in GBS?
- ) Reduction in the amplitude of muscle action potentials
- ) Slowed conduction velocity
- ) Conduction block in motor nerves
p. 1324
Acute motor axonal variety has tendency to be associated with which antibodies?
GM1 or GD1a
p.1325
Pharyngeal-cervical brachial associated with which antibody
GT1a
p.1325
Many patients with bizarre waking dreams or hallucinations after weeks of immobilization, seen in GBS
Oneiric hallucinations
p.1328
Plasma Exchange in GBS
removes a total of 200 to 250ml/kg of plasma in 4 to 6 treatments
p.1329
Dose of IvIg in GBS
0.4 g/kg per day for 5 days
A fairly consistent predictor of residual weakness and muscle atrophy?
Reduced amplitude of muscle action potentials; Widespread denervation p.1330
An acute or subacute symmetrical polyneuropathy frequently seen in critically ill and septic patients, particularly those with failure of multiple organs
Critical illness polyneuropathy
p.1330
Findings in critical illness polyneuropathy
Primary axonal process with early denervation, and normal CSF
The many systemic mediators of sepsis are toxic to the peripheral nervous system, _______________has been proposed as one such endogenous toxin causing neuropathy
Tumor Necrosis Factor p.1330
2 main presentations in Acute Sensory neuronopathy
Limb ataxia with no dysarthria or nystagmus
Generalized facial and truncal numbness that involved proximal and distal sensory areas
p.1331
Most salient identifying feature for gangliopathy
Early proximal symptoms
p.1331
Electrophysiologic studies in acute sensory neuronopathy
Absent or slowed sensory conduction, no abnormalities in motor nerve conduction or signs of denervation p.1331
A severe, rapidly advancing, symmetrical and mainly motor polyneuropathy-often with abdominal pain, psychosis and convulsions
Porphyric polyneuropathy p.1331
Metabolic defect in acute porphyria
Defect in the liver, marked by increased production and urinary excretion of Porphobilinogen, and porphyrin precursor 🔺aminolevulinic acid p.1331